pacap38 chemical (Bachem)
Structured Review

Pacap38 Chemical, supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pacap38+chemical/pmc11735793-66-0-1?v=Bachem
Average 90 stars, based on 1 article reviews
Images
1) Product Images from "PACAP regulates neuroendocrine and behavioral stress responses via CRF-containing neurons of the rat hypothalamic paraventricular nucleus"
Article Title: PACAP regulates neuroendocrine and behavioral stress responses via CRF-containing neurons of the rat hypothalamic paraventricular nucleus
Journal: Neuropsychopharmacology
doi: 10.1038/s41386-024-02016-9
Figure Legend Snippet: A A schematic coronal section from the rat brain atlas illustrating cannula implantation into the right lateral ventricle (left panel) and the experimental timeline (right panel) ( B ) PACAP38-injected animals ( n = 8) showed a significant reduction in active coping behavior, as indicated by decreased struggling, and an enhancement of immobility (floating behavior) compared to aCSF-injected controls ( n = 6). Data are expressed as mean ± SEM. * p < 0.05, ** p < 0.01 vs aCSF-injected controls (Student's t- test unpaired).
Techniques Used: Injection
Figure Legend Snippet: A Schematic coronal sections from the brain atlas showing brain regions examined (gray shaded). B Representative photomicrographs showing c-Fos positive cells in rats exposed to forced swim stress and microinjected either with aCSF or PACAP38. The lower panels show c-Fos quantification presented as bar graphs in the PVN ( C ) LS ( D ) and BNST ( E ). There was a significant increase of stress-induced c-Fos expression in the parvocellular part of the PVN, ventral LS and latero-dorsal part of the BNST of PACAP38-treated animals compared to aCSF-injected controls. Abbreviations: 3 V third ventricle, AC anterior commissure, BNST bed nucleus of the stria terminalis, BNSTld latero-dorsal part of the BNST, BNSTlp latero-posterior part of the BNST, BNSTma medial-anterior part of the BNST, CC corpus callosum, LS lateral septum, LSd lateral septum dorsal, LSv lateral septum ventral, LV lateral ventricle, opt optic nerve, PVN paraventricular nucleus of the hypothalamus, pcPVN parvocellular part of the PVN, mcPVN magnocellular part of the PVN. N = 6–8 animals per group. Scale bars: 100 µm at lower magnification, 25 µm at higher magnification images. Data are expressed as mean ± SEM. * p < 0.05 vs aCSF-injected controls (Student’s t- test).
Techniques Used: Expressing, Injection
Figure Legend Snippet: A Schematic drawings of coronal sections of the rat brain showing the localization of the cannula tips within the PVN from rostral (−1.6 mm) to caudal (−1.88 mm) for bilateral microinjection of vehicle (white circles) and PACAP38 (black circles). B Intra-PVN microinjections of PACAP38 (150 and 15 pmol/site; n = 10 and 4) elicited significantly higher floating (passive coping) and reduced struggling (active coping) time compared to aCSF-injected controls ( n = 6). No significant effects were found on the swimming behavior between PACAP38-injected rats and controls. Data are expressed as mean ± SEM. * p < 0.05 ** p < 0.01 vs aCSF-injected controls (one-way ANOVA followed by Dunnet's multiple comparison post hoc test).
Techniques Used: Microinjection, Injection, Comparison
Figure Legend Snippet: A Schematic illustration of the experimental design with the timeline of blood sampling (red circles), drug infusion (green bar) and stress exposure (orange bar, forced swim, FS). Experiment started with insertion of the infusion device (bilateral injection cannulas connected to a microinfusion pump) at least 1 h before blood sampling started. Drugs were infused automatically at a constant flow rate over a period of 7.5 min without any stressful manipulations (e.g such as capturing or restraining animals) before and during the infusion procedure. Blood samples were collected at regular intervals before drug infusion under basal conditions (−35 and −15 min) and after drug infusion, but before stress exposure (−1 min) and after forced swim stress (10, 30, and 60 min). B Swim stress caused an increase in plasma ACTH levels in both intra-PVN PACAP38 ( n = 7) and aCSF-injected controls ( n = 7). Compared to controls, intra-PVN PACAP38-injected rats showed higher plasma ACTH levels during and after forced swim stress. However, basal levels did not differ between groups. The green bar indicates timing of intra-PVN infusion, the orange bar the forced swim (FS) stress exposure. Data are expressed as mean ± SEM. * p < 0.05 **** p < 0.0001 compared to basal timepoints (−35 and −15 min) in same treatment group; +++ p < 0.001 compared to vehicle-injected controls at same timepoint (two-way ANOVA followed by Bonferroni's multiple comparison post hoc test).
Techniques Used: Sampling, Injection, Clinical Proteomics, Comparison
Figure Legend Snippet: A Schematic drawing illustrating different subregions of the PVN and representative confocal images showing CRF (red) and c-Fos (blue) immunopositive neurons in the mpcPVN. B The lower panels show quantification of CRF (left panel) and CRF/c-Fos (middle and right panel) positive neurons presented as bar graphs in the mpcPVN. There was no significant difference in the total number of CRF neurons between PACAP38-treated animals and controls, but the number of CRF neurons that co-express c-Fos were significantly higher in the PACAP38-treated animals compared to controls. Note that in controls only 38% of CRF neurons expressed Fos, while in the PACAP38-treated animals the percentage of CRF neurons expressing c-Fos was 76%. Abbreviations: 3 V third ventricle, ns not significant. N = 3 animals per group. Scale bar: 50 µm. Data are expressed as mean ± SEM. * p < 0.05 ** p < 0.01 vs aCSF-injected controls (Student's t- test).
Techniques Used: Expressing, Injection
